Rtp Poon

1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

Josep M. Llovet, Thomas Decaens, Jean‐Luc Raoul et al. · Journal of Hepatology · 2012 · 100 citations

Medicine, Oncology, Pharmacology +11

A phase I/II trial of transarterial chemoembolization for hepatocellular carcinoma using a novel intrarterial drug eluting beads

Rtp Poon, Kelvin K. Ng, WK Tso et al. · 2007 · 22 citations

Medicine, Oncology, Pharmacology +17

47LBA Phase II trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinoma

T. Yau, P. Chan, Foon‐Yiu Cheung et al. · European Journal of Cancer Supplements · 2009 · 16 citations

Medicine, Oncology, Pharmacology +14

665 A PHASE I/II STUDY OF FORETINIB, AN ORAL MULTIKINASE INHIBITOR TARGETING MET, RON, AXL, TIE-2 AND VEGFR IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

Thomas Yau, Clarence Yen, P.-J. Chen et al. · Journal of Hepatology · 2011 · 10 citations

Medicine, Oncology, Pharmacology +12